Whitehawk Therapeutics (WHWK) Total Current Liabilities (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Total Current Liabilities data on file, last reported at $11.1 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 9.92% year-over-year to $11.1 million in Q1 2026; TTM through Mar 2026 was $11.1 million, a 9.92% decrease from a year earlier, with the FY2025 full-year figure at $14.5 million, down 14.96% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $11.1 million, down from $14.5 million in the prior quarter.
• Over the last five years, Total Current Liabilities for WHWK reached as high as $26.4 million in Q4 2023 and fell as low as $8.8 million in Q2 2025.
• Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $15.8 million in 2024.
• Across the five-year window, Total Current Liabilities surged 470.45% in 2022 and slumped 60.46% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $18.8 million in 2022, then jumped by 40.14% to $26.4 million in 2023, then plunged by 35.31% to $17.1 million in 2024, then declined by 14.96% to $14.5 million in 2025, then dropped by 23.85% to $11.1 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $11.1 million in Q1 2026, $14.5 million in Q4 2025, and $9.8 million in Q3 2025.